Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.690
-0.180 (-6.27%)
At close: Sep 18, 2024, 4:00 PM
2.686
-0.004 (-0.15%)
After-hours: Sep 18, 2024, 7:27 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $11.68 million as of September 18, 2024. Its market cap has increased by 108.57% in one year.
Market Cap
11.68M
Enterprise Value
8.01M
1-Year Change
108.57%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $56.87M to $11.68M, a decrease of -79.46%. That is a compound annual growth rate of -51.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 7.40M | 221.74% |
| Dec 29, 2023 | 2.30M | -72.29% |
| Dec 30, 2022 | 8.30M | -85.41% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anew Medical | 12.51M |
| QT Imaging Holdings | 12.50M |
| Universe Pharmaceuticals INC | 12.42M |
| Streamline Health Solutions | 12.27M |
| Sensei Biotherapeutics | 12.17M |
| BioRestorative Therapies | 12.11M |
| Dominari Holdings | 11.82M |
| Purple Biotech | 11.60M |